These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11932312)

  • 1. Demonstration of immunoglobulin G, A, and E autoantibodies to the human thyrotropin receptor using flow cytometry.
    Metcalfe R; Jordan N; Watson P; Gullu S; Wiltshire M; Crisp M; Evans C; Weetman A; Ludgate M
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1754-61. PubMed ID: 11932312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyrotropin receptor autoantibodies in serum are present at much lower levels than thyroid peroxidase autoantibodies: analysis by flow cytometry.
    Jaume JC; Kakinuma A; Chazenbalk GD; Rapoport B; McLachlan SM
    J Clin Endocrinol Metab; 1997 Feb; 82(2):500-7. PubMed ID: 9024244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affinity-enrichment of thyrotropin receptor autoantibodies from Graves' patients and normal individuals provides insight into their properties and possible origin from natural antibodies.
    Latrofa F; Chazenbalk GD; Pichurin P; Chen CR; McLachlan SM; Rapoport B
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4734-45. PubMed ID: 15356088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graves' immunoglobulins activate phospholipase A2 by recognizing specific epitopes on thyrotropin receptor.
    Di Cerbo A; Di Paola R; Menzaghi C; De Filippis V; Tahara K; Corda D; Kohn LD
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3283-92. PubMed ID: 10487700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.
    Kamijo K; Murayama H; Uzu T; Togashi K; Olivo PD; Kahaly GJ
    Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyrotropin (TSH) receptor autoantibodies do not appear to bind to the TSH receptor produced in an in vitro transcription/translation system.
    Prentice L; Sanders JF; Perez M; Kato R; Sawicka J; Oda Y; Jaskolski D; Furmaniak J; Smith BR
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1288-92. PubMed ID: 9100609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of monoclonal thyroid-stimulating and thyrotropin binding-inhibiting autoantibodies from a Hashimoto's patient whose children had intrauterine and neonatal thyroid disease.
    Kohn LD; Suzuki K; Hoffman WH; Tombaccini D; Marcocci C; Shimojo N; Watanabe Y; Amino N; Cho BY; Kohno Y; Hirai A; Tahara K
    J Clin Endocrinol Metab; 1997 Dec; 82(12):3998-4009. PubMed ID: 9398703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves' disease: epitope and binding study of two stimulatory TSHRAbs.
    Akamizu T; Moriyama K; Miura M; Saijo M; Matsuda F; Nakao K
    Endocrinology; 1999 Apr; 140(4):1594-601. PubMed ID: 10098493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of a monoclonal antibody to the thyrotropin receptor that acts as a powerful thyroid-stimulating autoantibody antagonist.
    Sanders J; Allen F; Jeffreys J; Bolton J; Richards T; Depraetere H; Nakatake N; Evans M; Kiddie A; Premawardhana LD; Chirgadze DY; Miguel RN; Blundell TL; Furmaniak J; Smith BR
    Thyroid; 2005 Jul; 15(7):672-82. PubMed ID: 16053383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitopes for thyroid stimulating and blocking autoantibodies on the extracellular domain of the human thyrotropin receptor.
    Tahara K; Ishikawa N; Yamamoto K; Hirai A; Ito K; Tamura Y; Yoshida S; Saito Y; Kohn LD
    Thyroid; 1997 Dec; 7(6):867-77. PubMed ID: 9459630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding.
    Dallas JS; Cunningham SJ; Patibandla SA; Seetharamaiah GS; Morris JC; Tahara K; Kohn LD; Prabhakar BS
    Endocrinology; 1996 Aug; 137(8):3329-39. PubMed ID: 8754759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay.
    Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP
    Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TSH receptor antibodies do not alter the function of gonadotropin receptors stably expressed in eukaryotic cells.
    Tonacchera M; Ferrarini E; Dimida A; Agretti P; De Marco G; De Servi M; Chiovato L; Cetani F; Vitti P; Pinchera A
    Eur J Endocrinol; 2004 Mar; 150(3):381-7. PubMed ID: 15012625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of functionally different types of pathological autoantibodies against thyrotropin receptor in Graves' patients sera by luminescent immunoprecipitation analysis.
    Minich WB; Loos U
    Exp Clin Endocrinol Diabetes; 2000; 108(2):110-9. PubMed ID: 10826518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human thyrotropin (TSH) receptor in a TSH binding inhibition assay for TSH receptor autoantibodies.
    Kakinuma A; Chazenbalk GD; Jaume JC; Rapoport B; McLachlan SM
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2129-34. PubMed ID: 9215283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoprecipitation analysis of pathological autoantibodies in Graves' patients' sera using biotinylated human thyrotropin receptor labeled with 125I-neutravidiny.
    Minich WB; Weymayer JD; Loos U
    Exp Clin Endocrinol Diabetes; 1999; 107(8):555-60. PubMed ID: 10612487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interaction of TSH receptor autoantibodies with 125I-labelled TSH receptor.
    Sanders J; Oda Y; Roberts S; Kiddie A; Richards T; Bolton J; McGrath V; Walters S; Jaskólski D; Furmaniak J; Smith BR
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3797-802. PubMed ID: 10523032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A TSHr-LH/CGr chimera that measures functional TSAb in Graves' disease.
    Giuliani C; Cerrone D; Harii N; Thornton M; Kohn LD; Dagia NM; Fiore E; Bucci I; Chamblin T; Vitti P; Monaco F; Napolitano G
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1106-15. PubMed ID: 22496495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective binding of thyrotropin receptor autoantibodies to recombinant extracellular domain of thyrotropin/lutropin-chorionic gonadotropin receptor chimeric proteins.
    Seetharamaiah GS; Zhuang J; Huang J; Patibandla SA; Kaithamana S; Tahara K; Kohn LD; Prabhakar BS
    Thyroid; 1999 Sep; 9(9):879-86. PubMed ID: 10524566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutral antibodies to the TSH receptor are present in Graves' disease and regulate selective signaling cascades.
    Morshed SA; Ando T; Latif R; Davies TF
    Endocrinology; 2010 Nov; 151(11):5537-49. PubMed ID: 20844004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.